Humana Inc. (HUM) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
HUM's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
HUM Revenue Analysis (2013–2024)
As of February 28, 2026, Humana Inc. (HUM) generated trailing twelve-month (TTM) revenue of $126.36 billion, reflecting strong growth of +11.1% year-over-year. The most recent quarter (Q3 2025) recorded $32.65 billion in revenue, up 0.8% sequentially.
Looking at the longer-term picture, HUM's 5-year compound annual growth rate (CAGR) stands at +12.7%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $117.76 billion in 2024, representing a new all-time high.
Revenue diversification analysis shows HUM's business is primarily driven by Insurance Segment (85%), and CenterWell Segment (15%). With over half of revenue concentrated in Insurance Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ELV (+12.4% YoY), HUM has underperformed the peer group in terms of revenue growth. Compare HUM vs ELV →
Peer Comparison
Compare HUM's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HUMCurrent | $126.4B | +11.1% | +12.7% | 1.5% | |
| ELV | $198.7B | +12.4% | +10.3% | 3.5% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $117.76B | +10.7% | $117.76B | 100.0% | $1.72B | 1.5% |
| 2023 | $106.37B | +14.5% | $106.37B | 100.0% | $3.38B | 3.2% |
| 2022 | $92.87B | +11.8% | $92.87B | 100.0% | $3.57B | 3.8% |
| 2021 | $83.06B | +7.7% | $83.06B | 100.0% | $3.35B | 4.0% |
| 2020 | $77.16B | +18.9% | $77.16B | 100.0% | $4.60B | 6.0% |
| 2019 | $64.89B | +14.0% | $64.89B | 100.0% | $3.46B | 5.3% |
| 2018 | $56.91B | +5.8% | $56.91B | 100.0% | $2.06B | 3.6% |
| 2017 | $53.77B | -1.1% | $53.77B | 100.0% | $4.02B | 7.5% |
| 2016 | $54.38B | +0.2% | $54.38B | 100.0% | $1.55B | 2.9% |
| 2015 | $54.29B | +11.9% | $54.29B | 100.0% | $2.43B | 4.5% |
See HUM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HUM Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare HUM vs AGIO
See how HUM stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is HUM's revenue growth accelerating or slowing?
HUM maintains +11.1% revenue growth, in line with its 5-year CAGR of +12.7%. TTM revenue stands at $126.4B. Growth rate remains consistent with historical average.
What is HUM's long-term revenue growth rate?
Humana Inc.'s 5-year revenue CAGR of +12.7% reflects the sustained expansion pattern. Current YoY growth of +11.1% is near this long-term average.
How is HUM's revenue distributed by segment?
HUM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.